- 2022.09.10
Lemzoparlimab Data Readout at ESMO 2022
Presentation details:
| Abstract Title: | Lemzoparlimab, a Differentiated Anti-CD47 Monoclonal Antibody, in Combination with Azacitidine (AZA) in Patients with Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS): Initial Clinical Results |
| Presentation Number: | 617O |
| Presenter: | Prof. Chunkang Chang, Director of Hematology Department of Shanghai Sixth People’s Hospital |
| Session: | Proffered Paper Presentation: Hematological malignancies |
| Location: | 7.3.Q – Quimper Auditorium, Paris Expo Porte de Versailles, France |
| Presentation Date/Time: | Saturday, September 10, 2022, 2:45 p.m. – 3:15 p.m. Central European Time |
The abstract is currently available on the ESMO website. Please visit the following link to read the full abstract.
I-Mab Conference Call Information:
Investors and analysts are invited to join the conference call at 8:00 a.m. Eastern Time for English session on September 12, 2022 via Zoom:
| Meeting URL: | https://i-mabbiopharma.zoom.us/j/89060238854?pwd=RXdBbVlJbElPdHBoeWtOVXlHU0pBQT09 |
| Meeting ID: | 890 6023 8854 |
| Passcode: | 887466 |